How we treat data.
Consent, provenance, minimization, oversight and auditability are the operating rules of our platform.
No clinical data enters our infrastructure without explicit, informed and revocable consent through institutional partners.
We track the origin of every data element and collect only what is required for the defined clinical or research purpose.
Every signal returned from the platform is reviewed by qualified clinicians. The platform supports clinical judgment; it does not replace it.
Access controls, encryption, logging and periodic third-party audit are baseline requirements.
Aligned with LGPD (Brazil), HIPAA (US) and international clinical data governance standards.
Building rare disease infrastructure, together.
If you are advancing a therapy, investing in the space, running a clinical program or coordinating patient identification — start a conversation with us.